Published by Todd Bush on June 11, 2026
CHEONGJU, South Korea, June 11, 2026 /PRNewswire/ -- ToolGen, Inc. (CEO Dr. Jong-Sang Ryu, KOSDAQ: 199800), a pioneer in CRISPR-Cas9 genome-editing technology, announced the successful inauguration of its advanced Genome-Edited Crop Field Testing Facility and the hosting of its Open Innovation Mini-Symposium at the Osong Innovation Circle in Cheongju, South Korea.
The newly commissioned facility represents a critical step in translating genome-editing innovations from the laboratory to commercial applications. Operating in full compliance with regulatory requirements, it will generate high-quality agronomic and performance data necessary to support product development, regulatory submissions, and global commercialization.
>> In Other News: These Underwater 'Living Pink Rocks' Help Store Carbon: Scientists Just Found Four New Species
With this launch, ToolGen has established a comprehensive platform integrating genome editing, trait development, field validation, and seed product advancement. The facility enables the evaluation of multiple crop species under real-world growing conditions. Field trials will focus on drought tolerance, herbicide tolerance, and enhanced seed oil composition to generate robust phenotypic datasets validating crop performance and scalability for global industrial applications.
To address rapidly increasing global demand for Sustainable Aviation Fuel (SAF) feedstocks, ToolGen is leveraging its new capabilities to advance a portfolio of genome-edited industrial oilseed crops—including pennycress, canola, carinata, camelina, Indian mustard, and castor bean. Through CRISPR-enabled trait improvement, ToolGen aims to enhance yield potential and oil content, securing sustainable feedstocks without competing with conventional food production systems.
Moving beyond traditional licensing, ToolGen is building an integrated vertical value chain encompassing trait development, seed production, and downstream commercial partnerships, focusing on Australia, Southeast Asia, and Europe.
"The Osong facility marks a significant milestone in evolving our seed business from research to product-focused commercialization," said Dan Sung, Executive Vice President of ToolGen's Seed Business Division.
CEO Dr. Jong-Sang Ryu added: "We are well positioned to contribute to the future of bioenergy across Australia, Asia, and Europe. Recent European patent proceedings do not affect ToolGen's fundamental intellectual property position or strategic commercial roadmap. ToolGen remains protected by a strong, independently developed next-generation patent portfolio that underpins our long-term competitive advantage and freedom to operate."
SOURCE ToolGen
Follow the money flow of climate, technology, and energy investments to uncover new opportunities and jobs.
Inside This Issue ⚡ JERA Invests in Koloma to Explore Natural Hydrogen as a Future Low-Carbon Energy 🔬 New CATF Tool Provides Framework for Self-Assessment and Strengthening of Biomass Carbon Remo...
Inside This Issue 🚛 MIT Startup Says It Can Turn Diesel Trucks Into Cheaper Hydrogen Haulers, See It at Disrupt 🏭 Baytown City Council Briefs: ExxonMobil Blue Hydrogen Agreement Approved 🌎 Colorad...
Inside This Issue 💂 Eni’s Douglas Platform Sets the Offshore CCS Blueprint 🌲 Pacolet Milliken Expands Its Biomass Platform With the Acquisition of Georgia Renewable Power 🧪 Metacon Receives EU Fun...
A new interactive tool from Clean Air Task Force (CATF) provides a practical framework for the self-assessment and strengthening of biomass carbon removal (BiCRS) protocols to help ensure that carb...
LanzaJet Secures Financing to Scale SAF Production and Supply Global Customers
CHICAGO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- LanzaJet, Inc., a leading next-gen fuels technology company and fuels producer, today announced fully committed new financing of at least $20 million to s...
44.01 and Frontier Advance Permanent CO₂ Storage Through In-Situ Mineralization
44.01's in-situ mineralization (ISM) process turns CO₂ into solid rock underground in a few years, after which the risk of reversal is functionally zero. >> In Other News: JERA Invests in ...
JERA Invests in Koloma to Explore Natural Hydrogen as a Future Low-Carbon Energy
JERA Co., Inc. (JERA), through its corporate venture capital arm JERA Ventures, has invested in Koloma, Inc. (Koloma), a U.S.-based natural hydrogen exploration and development company. The invest...
Follow the money flow of climate, technology, and energy investments to uncover new opportunities and jobs.